Company Filing History:
Years Active: 2019
Title: Innovations of Xiaomei He in CTLA4-Fc Fusion Proteins
Introduction
Xiaomei He is an accomplished inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of methods related to CTLA4-Fc fusion proteins. Her work has implications for therapeutic applications, including the manufacturing and characterization of important biopharmaceuticals.
Latest Patents
Xiaomei He holds 1 patent for her innovative methods concerning CTLA4-Fc fusion proteins. The patent outlines techniques for evaluating, identifying, and producing CTLA4-Fc fusion proteins, such as abatacept. These methods enable highly resolved evaluations that are crucial for manufacturing, characterizing, and monitoring the structure of abatacept over time or under varying conditions.
Career Highlights
Xiaomei He is currently employed at Momenta Pharmaceuticals, Inc., where she continues to advance her research in biopharmaceuticals. Her expertise in the field has positioned her as a valuable asset to her team and the broader scientific community.
Collaborations
Xiaomei collaborates with notable colleagues, including John Robblee and Yan Yin, who contribute to her research endeavors. Their combined efforts enhance the innovation and development of therapeutic solutions in the biotechnology sector.
Conclusion
Xiaomei He exemplifies the spirit of innovation in biotechnology through her work on CTLA4-Fc fusion proteins. Her contributions are paving the way for advancements in therapeutic applications, showcasing the importance of her research in the field.